Panbela Therapeutics (PBLA) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Panbela Therapeutics, Inc. has announced its return to compliance with Nasdaq’s listing requirements regarding bid price and the number of publicly held shares. This milestone is critical for the company’s continued presence on the stock market, ensuring its shares meet the necessary standards for trading and ownership distribution.
For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.